Search results
Results From The WOW.Com Content Network
The company now expects 2025 adjusted earnings per share of $7.55 to $7.70, compared with its previous forecast of at least $7.50. According to LSEG data, analysts were expecting an annual profit ...
Cardinal Health. [ 1] Cardinal Health, Inc. is an American multinational health care services company, and the 14th highest revenue generating company in the United States. Headquartered in Dublin, Ohio, the company specializes in the distribution of pharmaceuticals and medical products, serving more than 100,000 locations. [ 2]
Growing appetite for weight loss drugs helps trigger an increase in Cardinal Health's revenue forecast. Cardinal Health says demand for weight loss drugs may level off but remain strong [Video ...
The Optum contracts, signed in 2015, contributed 16% of Cardinal's total revenue in fiscal year 2023, but the bulk of the shipments mainly comprised non-specialty medicines, Cardinal Health said.
Catalent, Inc. ( Catalent Pharma Solutions) is a multinational corporation headquartered in Somerset, New Jersey. It is a global provider of delivery technologies, development, drug manufacturing, biologics, gene therapies and consumer health products. It employs more than 14,000 people, [ 2] including approximately 2,400 scientists and ...
Founded. 1987. Defunct. 1996. Pyxis Corporation was a San Diego company co-founded by Ronald R. Taylor and investor Tim Wollaeger in 1987. The company is the first to develop MedStation products in 1990 and is also a market leader for automated medication management, [ 1] developing an automated dispensing cabinet under the name Pyxis. [ 2]
For premium support please call: 800-290-4726 more ways to reach us
CareFusion was created in 2009 as a spinoff of medical technology businesses from Cardinal Health. [ 1] It began publicly trading on the New York Stock Exchange on September 1, 2009. [ 2] Cardinal's core business was drug distribution, a low-margin and low-risk, predictable business, with which the higher-margin, higher-risk medical technology ...